Cargando…

Prognostic assessment capability of a five-gene signature in pancreatic cancer: a machine learning based-study

BACKGROUND: A prognostic assessment method with good sensitivity and specificity plays an important role in the treatment of pancreatic cancer patients. Finding a way to evaluate the prognosis of pancreatic cancer is of great significance for the treatment of pancreatic cancer. METHODS: In this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xuanfeng, Yang, Lulu, Zhang, Dong, Wang, Xiaochuan, Bu, Xuefeng, Zhang, Xinhui, Cui, Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007739/
https://www.ncbi.nlm.nih.gov/pubmed/36906533
http://dx.doi.org/10.1186/s12876-023-02700-y
_version_ 1784905596271591424
author Zhang, Xuanfeng
Yang, Lulu
Zhang, Dong
Wang, Xiaochuan
Bu, Xuefeng
Zhang, Xinhui
Cui, Long
author_facet Zhang, Xuanfeng
Yang, Lulu
Zhang, Dong
Wang, Xiaochuan
Bu, Xuefeng
Zhang, Xinhui
Cui, Long
author_sort Zhang, Xuanfeng
collection PubMed
description BACKGROUND: A prognostic assessment method with good sensitivity and specificity plays an important role in the treatment of pancreatic cancer patients. Finding a way to evaluate the prognosis of pancreatic cancer is of great significance for the treatment of pancreatic cancer. METHODS: In this study, GTEx dataset and TCGA dataset were merged together for differential gene expression analysis. Univariate Cox regression and Lasso regression were used to screen variables in the TCGA dataset. Screening the optimal prognostic assessment model is then performed by gaussian finite mixture model. Receiver operating characteristic (ROC) curves were used as an indicator to assess the predictive ability of the prognostic model, the validation process was performed on the GEO datasets. RESULTS: Gaussian finite mixture model was then used to build 5-gene signature (ANKRD22, ARNTL2, DSG3, KRT7, PRSS3). Receiver operating characteristic (ROC) curves suggested the 5-gene signature performed well on both the training and validation datasets. CONCLUSIONS: This 5-gene signature performed well on both our chosen training dataset and validation dataset and provided a new way to predict the prognosis of pancreatic cancer patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-023-02700-y.
format Online
Article
Text
id pubmed-10007739
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100077392023-03-12 Prognostic assessment capability of a five-gene signature in pancreatic cancer: a machine learning based-study Zhang, Xuanfeng Yang, Lulu Zhang, Dong Wang, Xiaochuan Bu, Xuefeng Zhang, Xinhui Cui, Long BMC Gastroenterol Research BACKGROUND: A prognostic assessment method with good sensitivity and specificity plays an important role in the treatment of pancreatic cancer patients. Finding a way to evaluate the prognosis of pancreatic cancer is of great significance for the treatment of pancreatic cancer. METHODS: In this study, GTEx dataset and TCGA dataset were merged together for differential gene expression analysis. Univariate Cox regression and Lasso regression were used to screen variables in the TCGA dataset. Screening the optimal prognostic assessment model is then performed by gaussian finite mixture model. Receiver operating characteristic (ROC) curves were used as an indicator to assess the predictive ability of the prognostic model, the validation process was performed on the GEO datasets. RESULTS: Gaussian finite mixture model was then used to build 5-gene signature (ANKRD22, ARNTL2, DSG3, KRT7, PRSS3). Receiver operating characteristic (ROC) curves suggested the 5-gene signature performed well on both the training and validation datasets. CONCLUSIONS: This 5-gene signature performed well on both our chosen training dataset and validation dataset and provided a new way to predict the prognosis of pancreatic cancer patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-023-02700-y. BioMed Central 2023-03-11 /pmc/articles/PMC10007739/ /pubmed/36906533 http://dx.doi.org/10.1186/s12876-023-02700-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhang, Xuanfeng
Yang, Lulu
Zhang, Dong
Wang, Xiaochuan
Bu, Xuefeng
Zhang, Xinhui
Cui, Long
Prognostic assessment capability of a five-gene signature in pancreatic cancer: a machine learning based-study
title Prognostic assessment capability of a five-gene signature in pancreatic cancer: a machine learning based-study
title_full Prognostic assessment capability of a five-gene signature in pancreatic cancer: a machine learning based-study
title_fullStr Prognostic assessment capability of a five-gene signature in pancreatic cancer: a machine learning based-study
title_full_unstemmed Prognostic assessment capability of a five-gene signature in pancreatic cancer: a machine learning based-study
title_short Prognostic assessment capability of a five-gene signature in pancreatic cancer: a machine learning based-study
title_sort prognostic assessment capability of a five-gene signature in pancreatic cancer: a machine learning based-study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007739/
https://www.ncbi.nlm.nih.gov/pubmed/36906533
http://dx.doi.org/10.1186/s12876-023-02700-y
work_keys_str_mv AT zhangxuanfeng prognosticassessmentcapabilityofafivegenesignatureinpancreaticcanceramachinelearningbasedstudy
AT yanglulu prognosticassessmentcapabilityofafivegenesignatureinpancreaticcanceramachinelearningbasedstudy
AT zhangdong prognosticassessmentcapabilityofafivegenesignatureinpancreaticcanceramachinelearningbasedstudy
AT wangxiaochuan prognosticassessmentcapabilityofafivegenesignatureinpancreaticcanceramachinelearningbasedstudy
AT buxuefeng prognosticassessmentcapabilityofafivegenesignatureinpancreaticcanceramachinelearningbasedstudy
AT zhangxinhui prognosticassessmentcapabilityofafivegenesignatureinpancreaticcanceramachinelearningbasedstudy
AT cuilong prognosticassessmentcapabilityofafivegenesignatureinpancreaticcanceramachinelearningbasedstudy